Additionally, CELF1 is known to boost the migratory and invasive abilities of CRC cells and their resistance to chemotherapy by interacting with ETS2 mRNA, which results in heightened ETS2 expression. The gene discussed is CELF1; the disease is colorectal carcinoma.